362653 <common-name>Methyl 22-amino-2-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-18,26,31,44,49-pentahydroxy-30-methyl-21,35,38,54,56,59-hexaoxo-47-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-64-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-2-yl]oxy-7,13,28-trioxa-20,36,39,53,55,58-hexazaundecacyclo[38.14.2.23,6.214,17.219,34.18,12.123,27.129,33.141,45.010,37.046,51]hexahexaconta-3(66),4,6(65),8,10,12(64),14(63),15,17(62),23(61),24,26,29(60),30,32,41(57),42,44,46(51),47,49-henicosaene-52-carboxylate</common-name> <description>Methyl 22-amino-2-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-18,26,31,44,49-pentahydroxy-30-methyl-21,35,38,54,56,59-hexaoxo-47-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-64-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-2-yl]oxy-7,13,28-trioxa-20,36,39,53,55,58-hexazaundecacyclo[38.14.2.23,6.214,17.219,34.18,12.123,27.129,33.141,45.010,37.046,51]hexahexaconta-3(66),4,6(65),8,10,12(64),14(63),15,17(62),23(61),24,26,29(60),30,32,41(57),42,44,46(51),47,49-henicosaene-52-carboxylate has the chemical formula C84H92N8O35. With an average molecular weight of 1,774 g/mol, Methyl 22-amino-2-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-18,26,31,44,49-pentahydroxy-30-methyl-21,35,38,54,56,59-hexaoxo-47-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-64-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-2-yl]oxy-7,13,28-trioxa-20,36,39,53,55,58-hexazaundecacyclo[38.14.2.23,6.214,17.219,34.18,12.123,27.129,33.141,45.010,37.046,51]hexahexaconta-3(66),4,6(65),8,10,12(64),14(63),15,17(62),23(61),24,26,29(60),30,32,41(57),42,44,46(51),47,49-henicosaene-52-carboxylate is a heavy molecule.</description> <cas>1405-59-0</cas> <pubchem-id>16132274</pubchem-id> <chemical-formula>C84H92N8O35</chemical-formula> <weight>1773.7</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-09-01T12:00:59Z</created-at> <updated-at type="dateTime">2026-09-01T12:00:59Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC1C(C(CC(O1)OC2C3C(=O)NC(C4=C(C(=CC(=C4)O)OC5C(C(C(C(O5)CO)O)O)O)C6=C(C=CC(=C6)C(C(=O)N3)NC(=O)C7C8=CC(=C(C(=C8)OC9=CC=C2C=C9)OC1C(C(C(C(O1)COC1C(C(C(C(O1)C)O)O)O)O)O)O)OC1=CC=C(C=C1)C(C1C(=O)NC(C2=CC(=C(C(=C2)OC2=C(C=CC(=C2)C(C(=O)N1)N)O)C)O)C(=O)N7)O)O)C(=O)OC)N)O</moldb-smiles> <moldb-formula>C84H92N8O35</moldb-formula> <moldb-inchi>InChI=1S/C84H92N8O35/c1-28-45(97)18-35-20-46(28)122-47-19-33(9-16-44(47)96)55(86)75(109)91-60-64(100)31-5-11-38(12-6-31)120-49-21-36-22-50(74(49)127-84-72(108)69(105)66(102)52(125-84)27-117-82-70(106)67(103)63(99)30(3)119-82)121-39-13-7-32(8-14-39)73(126-53-25-42(85)62(98)29(2)118-53)61-80(114)90-59(81(115)116-4)41-23-37(94)24-48(123-83-71(107)68(104)65(101)51(26-93)124-83)54(41)40-17-34(10-15-43(40)95)56(76(110)92-61)87-78(112)58(36)88-77(111)57(35)89-79(60)113/h5-24,29-30,42,51-53,55-73,82-84,93-108H,25-27,85-86H2,1-4H3,(H,87,112)(H,88,111)(H,89,113)(H,90,114)(H,91,109)(H,92,110)</moldb-inchi> <moldb-inchikey>YECWLNHQVUKZLG-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">1772.566507</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>-3.4</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM358546</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>Methyl 22-amino-2-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-18,26,31,44,49-pentahydroxy-30-methyl-21,35,38,54,56,59-hexaoxo-47-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-64-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-2-yl]oxy-7,13,28-trioxa-20,36,39,53,55,58-hexazaundecacyclo[38.14.2.23,6.214,17.219,34.18,12.123,27.129,33.141,45.010,37.046,51]hexahexaconta-3(66),4,6(65),8,10,12(64),14(63),15,17(62),23(61),24,26,29(60),30,32,41(57),42,44,46(51),47,49-henicosaene-52-carboxylate</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organic acids and derivatives</superklass> <klass>Carboxylic acids and derivatives</klass> <subklass>Amino acids, peptides, and analogues</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0312714</sync-id> <structure-inchikey>YECWLNHQVUKZLG-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>1000000402800000000800000000c00000000000920000000000002000000080000040004040020020400008800000000800000000080000001001000400000000802000a000400000080023000000000a08000020101802208604000400000000000000100018000400000001000100000000200000000080000000000001010240000400800010040002000008008800010000000000200002000204000010008000400100000000000004c0000000002000000800000100500000408000000000002000000002100000000000000008000000004002000401200080001000810200000800800020042003400400460004800000020440800000000200000</structure-fingerprint> <structure-pattern-fingerprint>771ef7f89737ef78edfe5bf7cfbbfafbda7575fff59fa0f89f7f62f6db37eb6dfee285f613b6b66ccf5b5b6ce1dd3e31bdf34ff4e09f7a757fefff79fbebe196df13dedd7fafbee2da9013f21eff63436dd6d5cd776d9fbfd3fe7fe746fb5fdfedf865bf3c6df67973bed68ffffcc24d79d6b3d2fb9ff5afb9fb6ff7e3d9dbc7f3cfbb19dffcbe6aff9f0bf6cd3e46ee7b5ddf7bfd479ffef4bf0ebf66fd8fcc8fdf13b7bbf3f7bb0bc6ef6ebf7ff5d75ffdafcfab4f1af2f8b4caf4cce3da5effbd12bdddff53bb7fc1ffeef7d74fbb9e717df423757c73cd797faeeee9132fbbbceff5fa8b7f7ffb7cac5bdfd6e1aecedd7fbdf6e6e7afb7dbffdbdeffbf07</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAB/AAAAjQAAAIABBgBgAAAAAQMGAGAAAAAD AQYAYAAAAAMBBgBgAAAAAwEGAGAAAAACAgYAYAAAAAMBCAAgAAAAAggAIAAA AAIGAGAAAAADAQYAYAAAAAMBBgAoAAAAAwQIACgAAAADAgcAaAAAAAMCAQYA YAAAAAMBBkAoAAAAAwQGQCgAAAADBAZAKAAAAAMEBkBoAAAAAwMBBkAoAAAA AwQGQGgAAAADAwEIAGgAAAADAQEIACgAAAADAgYAYAAAAAMBBgBgAAAAAwEG AGAAAAADAQYAYAAAAAMBBgBgAAAAAwEIACAAAAACBgBgAAAAAgIIAGAAAAAB AQgAYAAAAAEBCABgAAAAAQEIAGAAAAABAQZAKAAAAAMEBkAoAAAAAwQGQGgA AAADAwEGQGgAAAADAwEGQCgAAAADBAZAaAAAAAMDAQYAYAAAAAMBBgAoAAAA AwQIACgAAAADAgcAaAAAAAMCAQcAaAAAAAMCAQYAKAAAAAMECAAoAAAAAwIG AGAAAAADAQZAKAAAAAMEBkBoAAAAAwMBBkAoAAAAAwQGQCgAAAADBAZAKAAA AAMEBkBoAAAAAwMBCAAoAAAAAwIGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMD AQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBCAAoAAAAAwIGAGAAAAADAQYA YAAAAAMBBgBgAAAAAwEGAGAAAAADAQYAYAAAAAMBCAAgAAAAAgYAYAAAAAIC CAAgAAAAAgYAYAAAAAMBBgBgAAAAAwEGAGAAAAADAQYAYAAAAAMBBgBgAAAA AwEIACAAAAACBgBgAAAAAQMIAGAAAAABAQgAYAAAAAEBCABgAAAAAQEIAGAA AAABAQgAYAAAAAEBCABgAAAAAQEIACgAAAADAgZAKAAAAAMEBkBoAAAAAwMB BkBoAAAAAwMBBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGAGAAAAADAQYA YAAAAAMBBgAoAAAAAwQIACgAAAADAgcAaAAAAAMCAQYAYAAAAAMBBkAoAAAA AwQGQGgAAAADAwEGQCgAAAADBAZAKAAAAAMEBkAoAAAAAwQGQGgAAAADAwEI ACgAAAADAgZAKAAAAAMEBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQCgA AAADBAZAaAAAAAMDAQYAYAAAAAMBBgAoAAAAAwQIACgAAAADAgcAaAAAAAMC AQcAYAAAAAECCABoAAAAAwEBBgBgAAAAAQMIAGgAAAADAQEGACgAAAADBAgA KAAAAAMCBwBoAAAAAwIBCABgAAAAAQEIAGgAAAADAQEGACgAAAADBAgAKAAA AAMCCAAoAAAAAwIGAGAAAAABAwcAYAAAAAECCABgAAAAAQELAAEAAQIAAgMA AwQABAUABQYABQcABwgACAkACQoACgsoAgoMIAwNAA0OAA4PaAwPEGgMEBFo DBESaAwSE2gMEhQgEBUgFRYAFhcAFxgAGBkAGRoAGhsAGhwAHB0AGR4AGB8A FyAADyEgISJoDCIjaAwjJGgMJCVoDCUmaAwlJwAnKAAoKSgCKCogJysAKywg LC0oAiwuAC4vAC8waAwwMWgMMTJoDDIzaAwzNGgMMzUgNTYgNjdoDDc4aAw4 OWgMOTpoDDo7aAwyPCA8PQA9PgA+PwA/QABAQQBBQgBBQwBDRABERQBFRgBG RwBHSABISQBJSgBJSwBITABHTQBGTgBATwA/UAA+UQAxUiBSUyBTVGgMVFVo DFVWaAxWV2gMV1hoDFZZAFlaAFpbAFtcKAJbXSBdXgBeXwBfYGgMYGFoDGFi aAxiY2gMY2RoDGNlIGVmIGZnaAxnaGgMaGloDGlqaAxqa2gMamwAbG0AbW4o Am1vIGxwAGdxIGJyAGFzIF50AHR1KAJ0diBZdwAieCANeQB5eigCeXsge3wA A30AAn4ABgEAQj0ASkUAWFNoDG9aADkIAGRfaAxrZmgMKgkAEw5oDBsWACYh aAx2LgA0L2gMOzZoDEIRAAAABgEGBQQDAgYREhMODxAGFxgZGhsWBiIjJCUm IQZnaGlqa2YGYGFiY2RfBjAxMjM0LwY3ODk6OzYGPj9AQUI9BkZHSElKRQZU VVZXWFMMCgwNDg8hJiUnKCoJDltdXl9kY2Vma2psbW9aEFJTVFVWWVpbXV50 di4vMDEQKywuLzQzNTY7OjkICSooJxArLC4vNDM1Njc4OQgJKignEHR2Li8w MVJTWFdWWVpbXV4XBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:59:36Z</structure-indexed-at> </compound>